Want to join the conversation?
$PVH now expects 2016 non-GAAP EPS of $6.45-6.55, which includes about $1.55 negative impact related to foreign currency exchange rates. Excluding this negative impact, non-GAAP EPS is expected to rise 13-15% from $7.05 in 2015. Revenue in 2016 is now projected to increase about 2% on both a constant currency and a GAAP basis as compared to 2015.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.